|
Ruiz-Cosano J, Conesa-Zamora P, González-Conejero R, Pérez-Ceballos E, Martínez-Francés A, Vicente V, Pérez-Guillermo M. Role of GSTT1 and M1 null genotypes as risk factors for B-cell lymphoma: influence of geographical factors and occupational exposure. Mol Carcinog. 2012 Jun;51(6):508-13. doi: 10.1002/mc.20814. Epub 2011 Jun 16. PubMed PMID: 21681823.
AÑO: 2012; IF: 4.269
|
21681823
|
Pérez-Andreu V, Teruel R, Corral J, Roldán V, García-Barberá N, Salloum-Asfar S, Gómez-Lechón MJ, Bourgeois S, Deloukas P, Wadelius M, Vicente V, González-Conejero R, Martínez C. miR-133a regulates vitamin K 2,3-epoxide reductase complex subunit 1 (VKORC1), a key protein in the vitamin K cycle. Mol Med. 2013 Jan 22;18:1466-72. doi: 10.2119/molmed.2012.00062. PubMed PMID: 23154637; PubMed Central PMCID: PMC3563709.
AÑO: 2012; IF: 4.469
|
|
Corral J, Antón AI, Quiroga T, González-Conejero R, Pereira J, Roldán V, Vicente V, Mezzano D. Influence of the F12 -4 C>T polymorphism on hemostatic tests. Blood Coagul Fibrinolysis. 2010 Oct;21(7):632-9. doi: 10.1097/MBC.0b013e32833a9048. PubMed PMID: 20814302.
AÑO: 2010; IF: 1.408
|
|
Pérez-Andreu V, Roldán V, López-Fernández MF, Antón AI, Alberca I, Corral J, Montes R, García-Barberá N, Ferrando F, Vicente V, González-Conejero R. Pharmacogenetics of acenocoumarol in patients with extreme dose requirements. J Thromb Haemost. 2010 May;8(5):1012-7. doi: 10.1111/j.1538-7836.2010.03800.x. Epub 2010 Feb 9. PubMed PMID: 20149073.
AÑO: 2010; IF: 5.439
|
|
Cambronero F, Vilchez JA, García-Honrubia A, Ruiz-Espejo F, Moreno V, Hernández-Romero D, Bonacasa B, González-Conejero R, de la Morena G, Martínez P, Climent V, Valdés M, Marín F. Plasma levels of von Willebrand factor are increased in patients with hypertrophic cardiomyopathy. Thromb Res. 2010 Jul;126(1):e46-50. doi: 10.1016/j.thromres.2010.01.010. Epub 2010 Feb 13. PubMed PMID: 20156645.
AÑO: 2010; IF: 10.407
|